已收盘 05-15 16:00:00 美东时间
-1.290
-7.90%
BrainsWay (NASDAQ:BWAY) released first-quarter financial results and hosted an ...
05-13 21:46
BrainsWay (NASDAQ:BWAY) affirms FY2026 sales outlook from $66.000 million-$68.000 million to $66.000 million-$68.000 million vs $66.350 million estimate.
05-13 19:34
BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. This is a 200 percent increase over earnings of $0.02 per share from the same
05-13 19:32
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Gainers Immutep (NASDAQ:IMMP) shares rose 135.4% to $0.74 during Wednesday's p...
04-15 20:05
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the completion of an additional $6
03-26 19:37
Dow futures down 0.2%. Hesai Group -ADR shares drop 6.6% after reporting lower quarterly earnings and sales. Other stocks also down in pre-market.
03-24 20:02
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has completed a $1 million
03-19 19:37
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
Top analysts change outlook on top names. HC Wainwright cut BWAY price target, Mizuho raised PENN target, Telsey slashed SFIX target, BTIG cut AVAV target, Barrington cut CURI target, Morgan Stanley raised HON target, Stifel cut CPB target, Wells Fargo raised MU target.
03-12 21:28